Publication
Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)
Journal Paper/Review - Jan 16, 2020
Metaxas Y, von Moos R, Rauch D, Appenzeller Christina, Waibel C, Schmid S, Froesch P, Biaggi-Rudolf C, Perrino M, Maconi A, Schneider M, Mark M, Ceresoli G L, Zucali P A, Pless M, Grosso F, Eboulet E I, Früh Martin, Swiss Group for Clinical Cancer Research (SAKK)
Metaxas, Y
2
0
Früh, Martin
Medizinische Onkologie und Hämatologie · Dept. I
124
37
Eboulet, E I
2
0
Grosso, F
2
0
Pless, M
13
0
Zucali, P A
3
0
Ceresoli, G L
2
0
Mark, M
5
0
Schneider, M
5
0
Maconi, A
2
0
Perrino, M
1
0
Biaggi-Rudolf, C
1
0
Froesch, P
2
0
Schmid, S
18
0
Waibel, C
1
0
Appenzeller, Christina
Medizinische Onkologie und Hämatologie · Dept. I
7
2
Rauch, D
7
0
von Moos, R
25
0
Swiss Group for Clinical Cancer Research (SAKK),
31
0